Pasithea Therapeutics KTTA Q3 2025 earnings

FAQ

When did Pasithea Therapeutics report Q3 2025 earnings?

Pasithea Therapeutics (KTTA) reported Q3 2025 earnings on November 13, 2025 before market open.

What were Pasithea Therapeutics's Q3 2025 revenue and EPS?

Pasithea Therapeutics reported eps of $-0.41 for Q3 2025.

How did Pasithea Therapeutics's Q3 2025 results compare year-over-year?

Compared to the same quarter a year prior, eps grew 85.7% from $-2.87.

Where can I find Pasithea Therapeutics's Q3 2025 SEC filings?

You can read the 10-Q periodic report (0001213900-25-110093) directly on SEC EDGAR. The filing index links above go to sec.gov.